Characteristic head drops and axial extension in advanced chorea-acanthocytosis

Movement Disorders

Volumn 25, Issue 10, 2010, Pages 1487-1491

  Schneider, Susanne A ^a,b   Lang, Anthony E ^c   Moro, Elena ^c   Bader, Benedikt ^d   Danek, Adrian ^d   Bhatia, Kailash P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acanthocytes; Chorea acanthocytosis; Head drops; Neuroacanthocytosis; Orobulbar features; Trunk extension; Trunk flexion

Indexed keywords

ACANTHOCYTOSIS; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CHOREA; DEMENTIA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; MYOPATHY; NEUROPATHY; NEUROPSYCHIATRY; PRIORITY JOURNAL; RARE DISEASE; SEIZURE;

ADULT; FOLLOW-UP STUDIES; HEAD MOVEMENTS; HUMANS; MIDDLE AGED; NEUROACANTHOCYTOSIS; SPASM;

EID: 77954984814     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23052     Document Type: Article

References (15)

1. Rampoldi L, Danek A, Monaco AP. Clinical features and molecular bases of neuroacanthocytosis J Mol Med 2002;80:475-491.
2. Ueno S, Maruki Y, Nakamura M, et al. The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis Nat Genet 2001;28:121-122.
3. Schneider SA, Walker RH, Bhatia KP. The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test Nat Clin Pract Neurol 2007; 3:517-525.
4. Dobson-Stone C, Velayos-Baeza A, Filippone LA, et al. Chorein detection for the diagnosis of chorea-acanthocytosis Ann Neurol 2004;56:299-302.
5. Dobson-Stone C, Velayos-Baeza A, Jansen A, et al. Identification of a VPS13A founder mutation in French Canadian families with chorea-acanthocytosis Neurogenetics 2005;6:151-158.
6. Al-Asmi A, Jansen AC, Badhwar A, et al. Familial temporal lobe epilepsy as a presenting feature of choreoacanthocytosis Epilepsia 2005;46:1256-1263.
7. Hardie RJ, Pullon HW, Harding AE, et al. Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases Brain 1991;114:13-49.
8. Dobson-Stone C, Danek A, Rampoldi L, et al. Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis Eur J Hum Genet 2002;10:773-781.
9. Walker RH, Liu Q, Ichiba M, et al. Self-mutilation in chorea-acanthocytosis: manifestation of movement disorder or psychopathology? Mov Disord 2006;21:2268-2269.
10. Chew NK, Mir P, Edwards MJ, et al. The natural history of Unverricht-Lundborg disease: a report of eight genetically proven cases Mov Disord 2008;23:107-113.
11. Shoumitro DEB. Self-injurious behaviour as part of genetic syndromes BR J PSYCH 1998;172:385-388.
12. Espelin DE, Done AK. Amphetamine poisoning: effectiveness of chlorpromazine N Engl J Med 1968;278:1361-1365.
13. Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice Cell 1996; 87:493-506.
14. Storch A, Kornhass M, Schwarz J. Testing for acanthocytosis a prospective reader-blinded study in movement disorder patients J Neurol 2005;252:84-90.
15. Walker RH, Jung HH, Dobson-Stone C, et al. Neurologic phenotypes associated with acanthocytosis Neurology 2007;68:92-98.